To further explore the role of the JAK/STAT3 pathway in liver fibrosis, we added colivelin to the 20-μM saffron treatment group and found colivelin reversed the inhibitory effect of saffron on LX-2 (Figs. 3c-3d). Here, STAT3 is linked to Hepatic fibrosis.